FEAR & GREED | Business News Q+A: The multi-trillion dollar industry ripe for disruption
Mar 25, 2026
Mark Britt, founder and CEO of preventative health company Tomorrow and serial entrepreneur behind iFlix, talks about shifting healthcare toward continuous, personalised care. He discusses quarterly biomarker testing, epigenetics and adaptive treatments. He also covers AI’s role in medical decisions, data privacy risks and why the goal is better healthspan, not immortality.
AI Snips
Chapters
Transcript
Episode notes
Healthcare Built For Sickness Not Thriving
- Healthcare is designed for acute sickness rather than ongoing wellbeing, leaving people 'not sick but not thriving.'
- Mark Britt built TMRW as a continuous care clinic delivering quarterly assessments and personalized plans to optimize daily health.
Quarterly Biomarker Tracking And Epigenetic Ageing
- TMRW runs deep testing: 100–150 blood biomarkers plus 1,700 epigenetic markers to measure pace of aging and organ-specific ages.
- They adapt personalized supplements and medications (e.g., daily 37-ingredient capsule) as biomarkers improve.
Prioritize Proven Medicine Over Experimental Hype
- Use proven, leading medical science rather than chasing experimental treatments for broad impact.
- TMRW aims to democratize longevity-style care at an affordable price similar to a gym membership.